
About GENOME LINK
GENOME LINK is a company based in Berkeley (United States) founded in 2017 by Yuta Matsuda, Kensuke Numakura, and Tomohiro Takano. GENOME LINK has raised $225 thousand across 3 funding rounds from investors including Berkeley SkyDeck, m3.com and Y Combinator. The company has 4 employees. GENOME LINK offers products and services including DNA Analysis Platform, Ancestry Reports, and Wellness Reports. GENOME LINK operates in a competitive market with competitors including Viome, Invitae, Helix, Color and Everlywell, among others.
- Headquarter Berkeley, United States
- Employees 4
- Founders Yuta Matsuda, Kensuke Numakura, Tomohiro Takano
- SectorsHealthcare
- Website category Hobbies and Leisure · Ancestry and Genealogy
- Emailβ’β’β’β’β’β’β’β’
- Website genomelink.io
- Social X Facebook Instagram
- Legal Name Genomelink, Inc.
- Total Equity Funding$225K (USD)
in 3 rounds
- Latest Funding Round$125K (USD), Seed
Sep 2021
- InvestorsBerkeley SkyDeck
& 4 more
- Employee Count4
Products & Services of GENOME LINK
GENOME LINK offers a comprehensive portfolio of products and services, including DNA Analysis Platform, Ancestry Reports, and Wellness Reports.
Platform for uploading DNA data to generate trait reports
Reports on ethnic and ancient heritage from DNA data
DNA-based advice on nutrition, fitness, and mental health
Funding Insights of GENOME LINK
GENOME LINK has successfully raised a total of $225K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $125 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $225,000
- Total Rounds 3
- Last Round Seed β $125,000
- Investors Count 5
All 3 funding rounds of GENOME LINK with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2021 | $125,000 | Seed | β | Y Combinator | β |
| Dec 2017 | $100,000 | Seed | β | Berkeley SkyDeck | β |
| Aug 2017 | – | Seed | β | 500 Startups Japan |
5 investors in total: 5 institutional.
Investors in GENOME LINK
GENOME LINK has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Berkeley SkyDeck, m3.com and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are accelerated via funding and educational programs. | – | ycombinator.com | Mountain View, United States | |
Startups are accelerated and incubated across diverse industries. | 2012 | skydeck.berkeley.edu | Berkeley, United States | |
Startup growth and funding support are provided by EXPACT. | 2018 | 500startups.jp | Shizuoka, Japan | |
Japan's members-only networking site for healthcare professionals is operated. | 2000 | m3.com | Tokyo, Japan | |
Sanamedi is engaged in medical device development consulting. | – | jomdd.com | Japan |
Investor details for GENOME LINK
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GENOME LINK
22 people are tracked at GENOME LINK (5 in leadership, 7 in board & advisors, 10 in team); the tracked headcount is 4.
| Name | Role | Group |
|---|---|---|
Yuta Matsuda | Co-Founder & COO | Leadership |
Kensuke Numakura | Co-Founder & CTO | Leadership |
Tomohiro Takano | Co-Founder & CEO | Leadership |
Taj Walton | Head, Product | Leadership |
Akiko Yoshida | B2c Marketing Research At The Ceo's Office | Leadership |
Seth Bindernagel | Advisor & Investor | Board & advisors |
Carlos Bustamante | Head of Science Advisory | Board & advisors |
Tomy Kamada | Advisor & Investor | Board & advisors |
Hiroaki Kitano | Advisor & Investor | Board & advisors |
Mya Thomae | Advisor & Investor | Board & advisors |
Andreas Stahl | Advisor | Board & advisors |
D.a. Wallach | Advisor & Investor | Board & advisors |
Kate Mironenko | Software Engineer | Team |
David Kravitz | Product Manager | Team |
Artem Chumak | Software Engineer | Team |
Nacho Urpi | Software Engineer | Team |
Sabrina Miller | Software Engineer | Team |
Stas Kulesh | Designer | Team |
Alya Yuzgina | Designer | Team |
Vlad Sadovenko | CX Designer | Team |
2 more people are available in the full profile.
Complete people profiles for GENOME LINK
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GENOME LINK
3 dated milestones of GENOME LINK across 4 years, from founding to its latest funding, stage changes and deals.
- Founded GENOME LINK is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $125K.
Competitors of GENOME LINK
GENOME LINK operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Invitae, Helix, Color and Everlywell, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| helix.com | 2015 | San Francisco, United States | $435M | – | Genomic database for clinical research is provided. | |
| color.com | 2013 | Burlingame, United States | $506.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| everlywell.com | 2014 | Austin, United States | $330M | 614 | At-home health tests for biomarkers, nutrition, and hormone analysis. | |
| variantbio.com | 2018 | Brooklyn, United States | $127.74M | – | Personalized therapeutics are developed using genomic data for rare diseases. | |
| newtopia.com | 2008 | New York, United States | $13.1M | – | Health management platform is provided for employers and insurers. | |
| counsyl.com | 2007 | San Francisco, United States | $112.89M | 503 | DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening | |
| digbihealth.com | 2018 | Mountain View, United States | $5.4M | – | Personalized healthcare is delivered through DNA and gut biome testing. | |
| goodstartgenetics.com | 2008 | Boston, United States | $32.16M | – | Molecular diagnostics for inherited genetic disease screening are provided. |
Detailed competitors of GENOME LINK
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GENOME LINK
The website of GENOME LINK (genomelink.io) receives about 1M visits a month and ranks #39,195 among all websites worldwide, #233 in Ancestry and Genealogy.
- Monthly visits1M
▼ 2.6% vs previous month
- Unique visitors397.5K
per month
- Global rank#39,195
among all websites
- Category rank#233
Hobbies and Leisure · Ancestry and Genealogy
- Bounce rate41%
- Pages per visit5.5
- Average visit2 min 25 sec
- DevicesDesktop 25% Β· Mobile 75%
Websites whose visitors overlap most with GENOME LINK. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| myheritage.com | 100% | 12.2M | #2,869 | View details | |
mytrueancestry.com | mytrueancestry.com | 89% | – | #155,002 | β |
| familytreedna.com | 88% | – | #34,420 | View details | |
| 23andme.com | 88% | 4.4M | #8,883 | View details | |
| ancestry.com | 86% | 37.5M | #497 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 29 similar websites and full traffic analytics for GENOME LINK
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 29 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to GENOME LINK
10 companies that operate in the same segment as GENOME LINK (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GENOME LINK
GENOME LINK was founded in 2017.
GENOME LINK is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Tomohiro Takano is the current CEO of GENOME LINK. They have also founded this company.
GENOME LINK is a funded company, having raised a total of $225K across 3 funding rounds to date.
GENOME LINK has 4 employees.
Genome Link was founded in 2017 in Berkeley, United States, as a provider in the genomics sector. An online platform is operated to store DNA data obtained from services such as 23andMe, Ancestry.com, and MyHeritage. Tools are offered for visualizing this data and deriving insights on ancestry, body traits, intelligence, and aptitudes, supporting user analysis in personal genomics.
GENOME LINK's top competitors include Viome, Helix and Variant Bio.
GENOME LINK offers DNA Analysis Platform, Ancestry Reports, and Wellness Reports.
GENOME LINK has 5 investors. Key investors include Berkeley SkyDeck, m3.com, Y Combinator, EXPACT, and Sanamedi.
GENOME LINK operates through Genomelink, Inc..
The website of GENOME LINK receives about 1 million visits a month and ranks #39,195 among all websites worldwide.